Remove 2024 Remove Diabetes Remove Private Practice Remove Relationship
article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. Eric 16:06 And people knew from an ethical standpoint.

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. The following is a summary of the spring meeting.

article thumbnail

Allowing Patients to Die: Louise Aronson and Bill Andereck

GeriPal

Louise 05:02 Yes, well, I don’t know about 2024, but in 2023, yes, it could happen. It was a patient that I had taken care of, actually, as a resident, who followed me into my growing private practice. He was a terrible diabetic. Widera and Smith have no relationships to disclose. It happened to my mother.